RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the cultivation and sale of Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. The company offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot, TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot, and Collagen Max Drink, a liquid form dietary supplement; and Barbie… Read more
Market Cap & Net Worth: RAJAF (RAJAF)
RAJAF (OTCQB:RAJAF) has a market capitalization of $1.02 Billion ($1.02 Billion) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #15907 globally and #6185 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RAJAF's stock price $9.22 by its total outstanding shares 111120000 (111.12 Million).
RAJAF Market Cap History: 2024 to 2025
RAJAF's market capitalization history from 2024 to 2025. Data shows growth from $766.73 Million to $1.02 Billion (0.00% CAGR).
RAJAF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RAJAF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
611.68x
RAJAF's market cap is 611.68 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $766.73 Million | $1.25 Million | -$226.26K | 611.68x | N/A |
Competitor Companies of RAJAF by Market Capitalization
Companies near RAJAF in the global market cap rankings as of March 19, 2026.
Key companies related to RAJAF by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
RAJAF Historical Marketcap From 2024 to 2025
Between 2024 and today, RAJAF's market cap moved from $766.73 Million to $ 1.02 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.02 Billion | +33.62% |
| 2024 | $766.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of RAJAF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.02 Billion USD |
| MoneyControl | $1.02 Billion USD |
| MarketWatch | $1.02 Billion USD |
| marketcap.company | $1.02 Billion USD |
| Reuters | $1.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.